Unusual Call Activity that needs immediate attention

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Below are some of the most unusual option activity from Friday’s action that needs to be monitored for Monday.

Lets take look at the Most Unusual Calls:

2409 LL December 20 2019 $9.50 Call for .30

2370 UBER December 27 2019 $29.50 Call for .85

1794 PYPL December 27 2019 $110 Call for .36

1214 LK December 20 2019 $31.50 Call for .95

1139 WORK December 13 2019 $23.50 Call for .50

873 IQ December 20 2019 $21.50 Call for .32

832 FLXN December 20 2019 $20 Call for .20

Most Unusual Puts

1490 KEY December 20 2019 $19.50 Put for .23